Cerebral gluconeogenic enzymes

Cerebral gluconeogenic enzymes, including pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and fructose-1,6-bisphosphatase, are responsible for the endogenous production of glucose and its metabolic intermediates within the central nervous system [Panov et al., 2014]. Although the brain's capacity for full gluconeogenesis was historically debated, these enzymes are now recognized as vital components of astrocytic metabolism, where they recycle carbon skeletons to maintain neurotransmitter levels such as glutamate and GABA [Schonfeld & Reiser, 2013]. The use of C5-derived substrates, specifically 3-hydroxypentanoate and 3-ketopentanoate, provides an alternative metabolic route to fuel these pathways when primary glucose metabolism is impaired. These C5-ketones are typically derived from the synthetic triglyceride triheptanoin, which serves as an anaplerotic agent to refill the tricarboxylic acid (TCA) cycle [Mochel, 2017]. By entering the TCA cycle as propionyl-CoA, these substrates bypass metabolic blocks such as Glucose Transporter Type 1 (Glut1) deficiency or pyruvate dehydrogenase complex deficiency [Roe et al., 2002]. This metabolic intervention supports the energetic demands of neurons and helps stabilize neuronal excitability, making these enzymes key therapeutic targets for treating epilepsy and various metabolic encephalopathies. Clinical applications focus on restoring the pool of TCA cycle intermediates to prevent energy crises in the brain during periods of metabolic stress.

Other names

Brain gluconeogenesis pathwayAstrocytic gluconeogenic enzymesAnaplerotic enzymes of the central nervous systemCerebral anaplerotic pathway

Triheptanoin (UX007) is a synthetic triglyceride that is metabolized into C5-ketone bodies, specifically 3-hydroxypentanoate and 3-ketopentanoate, which cross the blood-brain barrier. These C5-derived substrates are converted into propionyl-CoA and acetyl-CoA within brain cells, providing an alternative source of succinyl-CoA for the tricarboxylic acid (TCA) cycle through anaplerosis [Mochel, 2017; Roe et al., 2002]. This process bypasses metabolic blocks in glucose transport or pyruvate oxidation, supporting the flux through gluconeogenic enzymes like phosphoenolpyruvate carboxykinase (PEPCK) to maintain neurotransmitter pools and cellular energy levels [Panov et al., 2014].